"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Cureus is now part of Springer Nature! Click here to read more about what this means for the Cureus community of readers, reviewers and authors.
Edward W. Swanson
Create your FREE profile now!

Join the discussion with physicians and researchers around the globe - sign up for your free Cureus account today.


Edward (Ned) Swanson, MD, is the co-founder and Chief Translational Medicine Officer at PolarityTE, Inc (Nasdaq: PTE), a biotechnology company utilizing the patient's own tissue and cells to regenerate functional tissue. He served as Chief Operating Officer and a member of the board before transitioning to his current role as Chief Medical Officer. Prior to launching PolarityTE, Dr. Swanson completed undergraduate work at the University of Pennsylvania in biomedical engineering and Harvard Medical School where he received his doctorate of medicine (M.D.). Following medical school, he pursued training in plastic and reconstructive surgery at The Johns Hopkins University School of Medicine residency program. His research interests include regenerative medicine, tissue engineering, transplant immunology, and tolerance induction, which he has studied thoroughly while at Penn, Harvard, Johns Hopkins, and now within PolarityTE.

Reviewer Keywords
plastic and reconstructive surgery regenerative medicine tissue engineering transplant immunology tolerance induction biotechnology craniofacial surgery
Publications (1)

Recent article categories: Plastic Surgery, Orthopedics, Trauma



My Professional Societies

American Medical Association (AMA)